01911.HK
China Renaissance Holdings Limited
HKSE · Financial Services · Financial - Capital Markets · CN
HKD 3.50
+2.94%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
2.1x
EV/EBITDA
−19.9x
Market Cap
HKD 1.83B
MomentumView details →
1D Return
+2.94%
YTD Return
−15.25%
RSI (14)
62.2
ValuationView details →
P/E (Fwd)
2.1x
EV/EBITDA
−19.9x
Market Cap
HKD 1.83B
RSI (14)
62.2
MomentumView details →
1D Return
+2.94%
YTD Return
−15.25%
Similar companies
Latest newsMore news →
NeuShen Therapeutics announced the completion of an oversubscribed Series B financing round of over $80 million on September 3, 2026.2d agoChina Renaissance Holdings reported interim results for the six months ended June 2026, with net profit of RMB 40.47 million, down 37.7% year-on-year, and revenue of RMB 412 million, down 3.0%.9d ago